title: pH-triggered drug-releasing magnetic nanoparticles for cancer therapy guided by molecular imaging by MRI.
authors.affiliation: Department of Chemical and Biomolecular Engineering, Yonsei University, Seoul 120-749, Republic of Korea.
authors.forename: Eun-Kyung
authors.initials: EK
authors.lastname: Lim
authors.forename: Yong-Min
authors.initials: YM
authors.lastname: Huh
authors.forename: Jaemoon
authors.initials: J
authors.lastname: Yang
authors.forename: Kwangyeol
authors.initials: K
authors.lastname: Lee
authors.forename: Jin-Suck
authors.initials: JS
authors.lastname: Suh
authors.forename: Seungjoo
authors.initials: S
authors.lastname: Haam
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology / Q000378:metabolism / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D045744:Cell Line, Tumor; D004317:Doxorubicin / Q000378:metabolism / Q000627:therapeutic use; D016503:Drug Delivery Systems / Q000379:methods*; D005290:Ferric Compounds / Q000737:chemistry; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008279:Magnetic Resonance Imaging; D008280:Magnetics; D017895:Manganese Compounds / Q000737:chemistry; D057054:Molecular Imaging; D053758:Nanoparticles / Q000737:chemistry*; D009369:Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism*; D011092:Polyethylene Glycols / Q000737:chemistry; D011721:Pyrenes / Q000737:chemistry; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000276:immunology; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D004317:Doxorubicin; D005290:Ferric Compounds; D017895:Manganese Compounds; D011092:Polyethylene Glycols; D011721:Pyrenes; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab; C551151:manganese ferrite; C030984:pyrene